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ABSTRACT                        The antifungal activities of amphotericin B/statin and nystatin/statin combinations 
against some opportunistic pathogenic fungi (Candida albicans, Candida glabrata, Paecilomyces 
variotii, Aspergillus fumigatus, Aspergillus flavus and Rhizopus oryzae) were investigated. The 
in vitro interactions between polyene antifungal drugs and different statins were evaluated 
using a standard chequerboard broth microdilution method. Most of the detected interactions 
were additive, though in some cases synergism was also observed. In most cases, the extents 
of inhibition were higher when these compounds were applied together, and as a result the 
concentrations of amphotericin B and a given statin, needed to prevent fungal growth, gener-
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Table 1. Examples of effective AMB/statin combinations.
Isolate / Combination 
[MIC alone (µg/ml)]a 
MIC (µg/ml) of AMB and MIC 
(µg/ml) of the different statins in 
combination [effect, IR]b 
C. albicans ATCC 90028
 AMB-ATO [1, 128] 0.5/0.391 [A, 1.13]
C. glabrata CBS 138
 AMB-ROS [1, 128]
 AMB-ATO [1, 32] 
0.5/0.391 [A, 1,02]
0.5/0.391 [A, 0.88]
P. variotii ATCC 36257
 AMB-SIM [0.125, 8]
 AMB-ATO [0.125, 32]
0.031/1.563 [A, 0.77]
0.063/0.391 [A, 0.81]
A. fumigatus SZMC 2486 
 AMB-FLV [4, 2]
 AMB-ATO [4, 64]
2/1.563 [A, 0.57]
2/0.391 [A, 1.15]
A. flavus SZMC 2521 
 AMB-FLV [8-16, 128] 4/12.5 [S, 1.62], 1/25 [A, 1.13]
R. oryzae CBS 109939
 AMB-SIM [2-4, 64]
 AMB-FLV [2-4, 2-3.125]
 AMB-ROS [2-4, >128]




1/6.25 [A, 0.74], 0.5/12.5 [A, 1.20]
a In brackets, MICs of AMB and the given statin are presented, respectively. MICs 
for statins were determined earlier by Nyilasi et al. (2010).
b Effective drug combinations are presented as the lowest concentrations of the 
combined drugs that caused total growth inhibition together; the first number 
indicates the concentration of AMB, and the second is the concentration of the 
given statin. In brackets, the type of the interaction (A, additive; S, synergistic) 
and IR values are presented, respectively. 
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Table 2. Examples of effective NYS/statin combinations.
Isolate / Combination 
[MIC alone (µg/ml)]a
MIC (µg/ml) of NYS and MIC 
(µg/ml) of the different statins 
in combination [effect, IR]b
C. albicans ATCC 90028
 NYS-LOV [2, 64]
 NYS-SIM [2, 8]




C. glabrata CBS 138
 NYS-LOV [1, 128]
 NYS-ROS [1, 128]
0.063/50 [A, 1.31]
1/12.5 [A, 0.91]
P. variotii ATCC 36257
 NYS-LOV [1, 64]
 NYS-SIM [1, 8]




A. flavus SZMC 2521 
 NYS-PRA [16, >128] 4/1.563 [A, 1.27]
R. oryzae CBS 109939
 NYS-LOV [>16, 128]
 NYS-FLV [>16, 2-3.125]
 NYS-ATO [>16, 32]
8/50 [A, 1.23]
16/1.563 [A, 1.08]
4/12.5 [A, 1.43], 1/25 [A, 1.47]
a In brackets, MICs of NYS and the given statin are presented, respectively.
b Effective drug combinations are presented as the lowest concentrations of the 
combined drugs that caused total growth inhibition together; the first number 
indicates the concentration of NYS, and the second is the concentration of the 
given statin. In brackets, the type of the interaction (A, additive; S, synergistic) 
and IR values are presented, respectively.

